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Abstract
Hantavirus infections are a major public health concern worldwide. Their widespread geographical distribution and their ability to
produce serious, often fatal, human disease underline the need for a system that allows manipulation of these viruses. We describe here the
first successful establishment of a reverse genetics technology for Hantaan virus, the prototype of the genus Hantavirus. The system offers
a unique opportunity to study the biology of hantaviruses, the pathogenesis of the diseases, and the efficacy of antiviral and prophylactic
measures against hantavirus infections.
© 2003 Elsevier Science (USA). All rights reserved.

Introduction
Hemorrhagic fever with renal syndrome (HFRS), caused
by viruses in the Hantavirus genus, family Bunyaviridae, is
a collective term for a group of clinically similar diseases.
Worldwide attention was first focused on HFRS during the
Korean War (1950-1953), when more than 3000 cases of
Korean hemorrhagic fever occurred among United Nations
troops. Since then, four distinct hantaviruses have been
shown to cause HFRS in Asia, Western Russia, Europe, and
Scandinavia (Lee et al., 1999). The recognition of a second
hantavirus-associated disease, termed hantavirus pulmonary
syndrome (HPS), in the U.S. in 1993 led to the discovery of
many additional hantaviruses throughout the Americas (Nichol et al., 1993). Today hantaviruses are considered as
globally distributed pathogens with major public health concerns in many countries. The occurrence of HFRS and HPS
is driven by the geographic distribution of the rodent reservoirs carrying the human pathogenic hantaviruses. Thus,
* Corresponding authors. Fax: ⫹1-204-789-2140.
E-mail addresses: Heinz_Feldmann@hc-sc.gc.ca (H. Feldmann),
Ramon_Flick@hc-sc.gc.ca (R. Flick).

HFRS is primarily found in Eurasia with more than 100,000
hospitalized cases annually and a mortality of up to 15%.
HPS is restricted to the Americas and has been identified in
31 U.S. states, Canada, and throughout Central and South
America. It is comparatively rare but shows a much higher
mortality rate (⬃40%) than HFRS. One of the HPS-causing
hantaviruses, Andes virus, also possesses the potential of
human-to-human transmission (Wells et al., 1998), which is
of considerable concern.
Currently, studies of hantavirus biology and disease
pathogenesis are limited by the lack of a reverse genetics
system for correlating specific gene regions with gene functions. Although introducing mutations into the genomes of
RNA viruses has created powerful tools for studying the
pathogenesis and the functions of essential genes/proteins
(Flick and Pettersson, 2001; Flick et al., 2002; Neumann et
al., 2002), and for developing attenuated vaccine candidates
(Murphy and Collins, 2002; Watanabe et al., 2002), the
manipulation of negative-strand RNA viruses is cumbersome using the typical RNA polymerase II transcription
system that has proven to work well for positive-strand
RNA viruses. In part, this is due to the absence of a 5⬘ cap
structure and a 3⬘ poly(A) tail at the termini of the negative-
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Fig. 1. Comparison of published nucleotide sequences of 5⬘ and 3⬘ termini of the Hantaan 76-118 strain. (A) The nucleotide sequences used for HTNV
minigenome constructs are based on the published sequence by Schmaljohn, 1990 (Accession No. X55901), which differs in some positions to a sequence
published by Chizhikov and colleagues (1995). (B) Comparison of the secondary structures predictions of the highly conserved terminal regions of the HTNV
L genome segment between the sequences listed under Accession No. X55901 (Schmaljohn, 1990) (top) and determined by Chizhikov et al. (1995) (bottom).

strand RNA genomes, common features usually generated
by RNA polymerase II transcription. It has been particularly
difficult to develop reverse genetics systems for bunyaviruses (Lopez et al., 1995; Bridgen and Elliott, 1996; Flick
and Pettersson, 2001) and all attempts for hantaviruses have
so far failed (Marczinke et al., 2001; A. Plyusnin and R.
Elliott, personal communication). Here we describe for the
first time the establishment of a reverse genetics system for
Hantaan virus (HTNV), the prototype of the genus Hantavirus.

Results and discussion
In the first step toward the establishment of a reverse
genetics system, a reporter gene is usually used to demonstrate functionality. Two systems have been used to generate artificial genomes or genome segments of negativestranded RNA viruses: the more commonly used and widely
established T7 RNA polymerase-driven system (T7 system)
(Fuerst et al., 1986), and, the more recently developed RNA
polymerase I driven system (pol I system) (Zobel et al.,
1993; Neumann et al., 1994). The pol I system, pioneered
by Hobom and colleagues (Zobel et al., 1993; Neumann et
al., 1994), has the advantage that the DNA-dependent RNA
polymerase does not have to be provided in trans (e.g., by a
recombinant vaccinia virus or plasmid cotransfection), since
this enzyme is already part of all eukaryotic cells. Furthermore, the initiation and termination of pol I derived transcripts are clearly defined (Zobel et al., 1993; Flick and
Hobom, 1999) and correct transcript ends can be produced
without the need of genetically engineered elements, such as
the hepatitis ␦ ribozyme. Our approach differed from those
of others in that we used the pol I system and templates with
the terminal nontranslated regions (NTR) of the HTNV

large (L) segment rather than those of the medium (M) or
small (S) segment (Fig. 1A). This strategy was based on the
assumption that the L segment ends represent a stronger
promoter than that of the S genomic segment to efficiently
transcribe and replicate this larger RNA molecule and on
our recent data obtained from the Uukuniemi virus reverse
genetics system, which experimentally supports this idea
(Flick and Pettersson, unpublished data). Two distinct sequences are published for the HTN NTR of the L segment
(Schmaljohn, 1990; Chizhikov et al., 1995). We used the
sequence determined by Schmaljohn (1990), because this
sequence allowed a more stable predicted panhandle-like
structure in the proximal promoter element (nine vs eight
potential base pairs) (Fig. 1B).
By combining the two NTR of the HTNV L-genome
segment, which are assumed to contain all regulatory elements needed for encapsidation, transcription, replication,
and packaging of the genome into progeny virus particles,
with the chloramphenicol acetyl transferase (CAT) reporter
gene, we generated an artificial hantaviral genome segment
(minigenome), which was inserted into two different pol I
system vectors (pRF207, pRF240) (Flick, unpublished
data). Subsequently, each plasmid was transfected into either a mixture of baby hamster kidney cells (BHK-21) and
monkey kidney cells (VeroE6) (Fig. 2A) or human embryonic kidney cells (293T) (Fig. 2B) to generate CAT-containing RNA minigenomes through the activity of the pol I.
For subsequent transcription, replication, and encapsidation of these pol I generated artificial segments, the viral
polymerase protein (L) and the nucleocapsid protein (N) are
needed (Figs. 2A and 2B). Therefore, cells transfected with
HTNV minigenome constructs were first superinfected with
HTNV (strain 76-118) under biosafety level 3 conditions
(Fig. 2A). To create optimal conditions, we used a combination of BHK-21 and VeroE6 cells. BHK-21 cells possess
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Fig. 2. Development of a pol I driven reverse genetics system for HTNV. (A) A mixture of BHK-21 and VeroE6 cells was transfected with pol I driven HTNV
L-CAT minigenome constructs. Cells were superinfected with HTNV, strain 76-118, 20-24 h posttransfection. Subsequently, cells were harvested 24 h p.i.
(44-48 h posttransfection) and minigenome transcription/replication was measured by detection of CAT activity. (B) 293T cells were transfected with pol
I driven constructs expressing different HTNV L-CAT minigenomes. To provide the viral polymerase and nucleocapsid proteins for minigenome
encapsidation, replication, and transcription, cells were cotransfected with the appropriate CMV-driven expression plasmids (pWRG/HTN-L, pWRG/HTNS). (C) Schematic presentation of transcription and replication of pol I driven HTN L-CAT minigenomes. The constructs pRF131, pRF135, and pRF279 are
transcribed into artificial vRNA segments (minigenomes), whereas pRF295 is generated as a cRNA-oriented molecule.

a higher transfection efficiency than VeroE6 cells and are
suitable for the murine pol I driven HTNV minigenome
constructs (pRF135, pRF279; Fig. 4) (Flick and Pettersson,
2001), whereas VeroE6 cells are better for HTNV infection
and propagation. We harvested the superinfected cell cultures 24 h p.i. (44 – 48 h posttransfection) and measured
CAT activity, an indicator for successful transcription and
replication of the artificial genome segment, by thin layer
chromatography using commercially available kits Fig. 3).
Significant reporter gene activity could be detected in superinfected vs noninfected control cells (Fig. 3, Lane 6:
69% vs 20%, and Lane 7: 58% vs 12%). CAT expression
level of superinfected cells was comparable to those that
were obtained using a previously established reverse genetics system for the phlebovirus Uukuniemi (Flick and Pettersson, 2001; Flick et al., 2002) and the orthomyxovirus
influenza A (Neumann et al., 1994). Our data support the
notion that the viral proteins necessary for transcription and
replication of the minigenomes are expressed early after
infection and that the relatively slow release of virus particles is not due to a lack of replicated vRNA genome segments or an insufficient amount of viral proteins during an
early stage of the infection cycle. It remains to be determined if VeroE6 cells enhanced the rescue through a more
efficient propagation of minigenome-containing recombinant viral particles or if they provided specific cellular
factors that favored a more efficient rescue.

To optimize the system and reduce background CAT
activity from a potential cryptic promoter located in the pol
I vector that we used, we inserted a series of stop-codons
downstream of the RNA pol I terminator region (Flick and
Pettersson, 2001). Transfection of BHK-21/VeroE6 cells
with the resulting plasmid, pRF279 (Fig. 4), showed a
notably reduced CAT activity background as compared to
pRF135, without stop codons (Fig. 3, Lanes 6 vs 7). Despite
background reduction of about 40%, some remaining CAT
signal could still be detected after transfection of the HTNV
minigenome cassette only (Fig. 3, Lane 7). This phenomenon has also been observed by other groups attempting to
establish reverse genetics systems for hantaviruses (A. Plyusnin and S. Nichol, personal communication). A likely
reason for this observation is the presence of a sequence
located in the 3⬘ NTR of some of the hantaviral genome
segments, which serves as a cryptic promoter site in the
minigenome plasmids. Replacing the sequence preceding
the CAT gene (3⬘ vRNA/5⬘ cRNA) by noncoding regions of
other bunyaviruses (e.g., Uukuniemi virus, Rift Valley Fever virus, Crimean-Congo Hemorrhagic Fever virus) eliminated the background signal, confirming the role of this
element as a cryptic promoter site (Flick and Pettersson,
2001 and Bouloy and Flick, unpublished data).
The ultimate aim of our work was to develop an infectious clone of HTNV. To achieve this, the viral polymerase
and nucleocapsid proteins have to be provided in an alter-
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Fig. 3. Graphic representation of CAT activities from HTN minigenome
rescue experiments. Lane 1 to 5: Control experiments to evaluate the
reporter gene background of the HTNV reverse genetics system. CAT
activity was determined after HTNV infection of BHK-21/VeroE6 cells or
293T cells (Lane 1), after transfection of two different pol I vector plasmids
(Lane 2), and after transfection of HTNV specific expression plasmids
(pWRG/HTN-L and pWRG/HTN-S) (Lane 3). Cell lysates were further
analyzed after cotransfection of HTNV minigenome pRF279 and either
HTNV-L or HTNV-S expression plasmids (Lanes 4 and 5). Lanes 6 to 8:
HTNV minigenome transfections with pRF135 (Lane 6), pRF279 (Lane 7),
or pRF295 (Lane 8) and HTNV superinfections were performed as illustrated in Fig. 2A and CAT activity was determined in the BHK-21/VeroE6
or 293T/VeroE6 cell lysates 44-48 h posttransfection. Lanes 9 and 10:
293T cell lysates were analyzed 24-48 h posttransfection after cotransfection of HTNV minigenome constructs pRF131 (Lane 9) or pRF295 (Lane
10) and the two HTNV expression plasmids for the L and N proteins
(pWRG/HTN-L and pWRG/HTN-S) (illustrated in Fig. 2B). All transfections were done at least three times.

native way to helper virus superinfection. As a step toward
this goal, we developed CMV-driven expression plasmids
for the HTNV L and N proteins and cotransfected both these
plasmids (pWRG/HTN-L, pWRG/HTN-S) together with
the minigenome construct, pRF131 (Fig. 2B). To take advantage of the high transfection efficiency of 293T cells, we
used the human pol I promoter system for this approach
(Neumann et al., 1999). Cells were harvested 24-48 h posttransfection and cytoplasmic extracts were analyzed for
reporter gene activity. The CAT activity in cell lysates from
the cotransfected cells was higher than observed in cells
transfected with only the minigenome, indicating the successful rescue of pol I driven HTNV minigenomes without
helper virus superinfection (Fig. 3, Lane 9). Moreover, these
results demonstrate expression of functional HTNV L- and
N-proteins driven by the CMV promoter (pWRG/HTN-L,
pWRG/HTN-S).
Both strategies, helper virus superinfection (Fig. 2A) and
plasmid cotransfection (Fig. 2B), confirmed the ability of
the artificial genome segments to serve as templates for
transcription. To demonstrate replication of these minigenomes, we generated HTNV minigenome constructs,
which are transcribed by the cellular RNA pol I into (⫹)sense cRNA (pRF295) rather than vRNA (pRF131) molecules (Figs. 2C and 4). These HTNV cRNA minigenomes

have to undergo replication (cRNA 3 vRNA) prior to
serving as templates for the generation of viral mRNA
molecules (vRNA 3 mRNA) (Fig. 2C). Following cotransfection of pRF295 with the HTNV-L and -N expression
plasmids, CAT activity could be detected in cell extracts
(Fig. 3, Lane 10). This demonstrates that the viral L protein
mediates transcription and replication of pol I driven minigenomes and confirms that the L- and N-proteins expressed
under the control of the CMV promoter were functional.
Furthermore, the cRNA minigenome (pRF295) could also
be rescued using the helper virus-driven system. However,
the reporter gene expression rate was lower (Fig. 3, Lane 8)
compared to vRNA transcripts (Fig. 3, Lanes 6 and 7). All
results were confirmed by at least three independent experiments including a series of control experiments (Fig. 3,
Lanes 1 to 5) to exclude false positive results.
This reverse genetics system is a breakthrough in hantavirus research. It is the first time that a functional recombinant hantavirus polymerase has been expressed. Furthermore, the successful rescue of HTNV minigenomes in the
absence of helper virus makes it possible to use this reverse
genetics system outside of a containment laboratory. Using
the system we described, it will be possible to determine
important regulatory elements of virus replication (Fuerst et
al., 1986; Flick and Hobom, 1999; Flick et al., 2002) and,
thus, should be useful for antiviral drug screening. Following further development and optimization, this system will
facilitate studies of the biology of hantaviruses and the
pathogenesis of HFRS. Thus, it will greatly improve the
chances to develop urgently needed prophylactic measures
and more feasible therapeutic interventions for these important human pathogens. Furthermore, the establishment of
this reverse genetics system is an example of the usefulness
of the pol I system to drive reverse genetics systems for
viruses that do not replicate in the nucleus, such as the
bunyaviruses.

Materials and methods
Cells and virus
BHK-21, 293T, and VeroE6 cells (American Type Culture Collection) were grown on plastic dishes in Glasgow or
Eagle’s minimal essential medium (GMEM/EMEM), supplemented with 7.5% fetal calf serum, 2mM L-glutamine,
100 IU penicillin/ml, and 100 g streptomycin/ml. HTNV,
strain 76-118, was used for all experiments. Cells were
infected with a multiplicity of infection (m.o.i.) of approximately 0.1-1 PFU/cell.
Construction of plasmids
Plasmids designed for the transcription of HTNV vRNA
or cRNA molecules by the RNA pol I carried the rDNA
promoter (⫺251 to ⫺1 relative to the 45S pre-rRNA start
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Fig. 4. Schematic diagram of different HTNV L-CAT minigenomes used
for reverse genetics studies. The human and murine RNA polymerase I (pol
I) promoters are designated as PpolI(murine) and PpolI(human). The murine pol
I terminator sequence is indicated as TpolI. vRNA minigenome constructs
pRF131, pRF135, and pRF279 contain CAT reporter genes in antisense
orientation, whereas a cRNA transcription cassette in sense orientation was
inserted in construct pRF295. The CAT gene is flanked by the nontranslated regions (NTR) of HTNV L segment; 40 nt represents the 5⬘ vRNA (or
3⬘ cRNA) and 37 represents the 3⬘ vRNA (or 5⬘ cRNA) part (Fig. 1)
(Schmaljohn, 1990). For background reduction of CAT activity stop
codons (indicated with a white box) were inserted adjacent to the pol I
terminator.

point) and terminator region (⫹571 to ⫹745 relative to the
3⬘ end of the 28S rDNA) of the murine rDNA (Zobel et al.,
1993). Between these two elements, the 5⬘ and 3⬘ NTR
of the HTNV L segment (Schmaljohn, 1990) (Accession
No. X55901) (Fig. 1A) were precisely inserted in either
antisense (primers RF132/RF133 or RF132/RF131;
RF131: 5⬘-AATGAAGACGTTATTTAGTAGTAGTATGCTCCGG-AAAATGAAAAAGAAAGAAAGCTTACGCCCCGCCCTGCCACTC, RF132:
5⬘-AATGAAGACGGGGGTAGTAGTAGACTCCCTAAATAACAAACTCTGAAAAGAATGGAGAAAAAAATCACTGGATATACC, RF133: 5⬘-ATTGAAGACGTAGGTTAGTAGTAGTATGCTCCGGAAAATG) or in sense
orientation (primers RF302/RF303; RF302: 5⬘-AATGAAGACGGTATTTAGTAGTAGACTCCCTAAATAACAAACTCTGAAAAGAATGGAGAAAAAAATCACTGGATATACC, RF303:
5⬘-AATGAAGACGGGGGTAGTAGTAGTATGCTCCGGAAAATGAAAAAGAAAGAAAGCTTACGCCCCGCCCTGCCACTCATCGC) for vRNA or cRNA transcription, respectively
[cleavage sites are marked in bold; CAT reporter gene sequences
are marked in italics, and HTNV L-NTRs are underlined]. For
sensitive detection of protein expression following transcription
and replication, the open reading frame of the CAT gene was
inserted. Using this strategy, we generated two vRNA [pRF131
(human pol I promoter) and pRF135 (murine pol I promoter)], and
a single cRNA construct [pRF295 (human pol I promoter)] (Fig.
4), which following transfection into cells (BHK-21, 293T, and
VeroE6) result in transcripts lacking 5⬘ and 3⬘ modifications [e.g.,
cap structure, poly(A) tail] (Fig. 2C) (Zobel et al., 1993; Flick and
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Hobom, 1999). All constructs were verified by dideoxysequencing using an ABI PRISM310 sequencer.
For the expression of HTNV-specific proteins, plasmids
containing the HTNV L gene or N gene controlled by a
CMV promoter were constructed. The plasmid containing
the HTNV L gene, designated pWRG/HTN-L(UU5), was
constructed as follows: the L gene was excised from plasmid puc18HTN-L(PP3) using BspEI (blunted), gel purified,
and then ligated into the NotI site (blunted) of a CMV promoter-containing expression vector, pWRG7077. pWRG7077
has been described previously (Schmaljohn et al., 1997).
The source of the L gene, puc18HTN-L(PP3), was constructed by RT-PCR amplification of the full-length L gene
from HTNV 76-118 RNA in two parts, followed by ligation
into a puc18-based vector. The HTNV N gene was subcloned from a previously described plasmid (Schmaljohn et
al., 1986) using forward primer HTNS20-39F (5⬘CGAGATCTAGAGCTACTAGAACAACG) and reverse
primer HTNS15527-1535R (5⬘-CGAGATCTGATCAAATGAAATCTAC). The PCR product was cut with BglII
(in bold) and ligated into the BglII site of pWRG7077 to
give pWRG/HTN-S.
Transfection and CAT assays
Transfection and CAT assays were performed as described previously (Flick and Pettersson, 2001; Flick et al.,
2002).
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